Unkategorisiert
Aftermovie of the 10th AFNET EHRA Consensus Conference
From May 5–7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France.
We captured the inspiring atmosphere and some voices of the participants, bringing them together in this aftermovie. A heartfelt thank you to everyone whose ideas and dedication made this event a true success!
Impressions of the 10th AFNET EHRA Consensus Conference
From May 5 to 7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France. Below are some impressions of the presentations, breakout sessions and the program around it
MAESTRIA-AFNET 10 – Collection of blood samples
Beiträge AKTUELLES Mo, 07.04.2025 MAESTRIA-AFNET 10 – Collection of blood samples Collection and procedure of blood samples within MAESTRIA-AFNET 10 Collection:A total of 26 tubes will be collected for one patient: Please find a detailed procedure for the collection of blood samples in the study protocol (see Appendix 7, page 47+48). Labelling:The samples collected will … Read more
MAESTRIA-AFNET 10 – 3rd Investigator Meeting
Beiträge AKTUELLES Mo, 07.04.2025 MAESTRIA-AFNET 10 – 3rd Investigator Meeting Prof. Goette emphasized that it is very important not only to recruit further permanent AF patients, but also to keep the patients in the study until 1-year follow up. This final data is essential to correlate it with the data from Baseline visit. All collected … Read more
EAST-STROKE Videointerview
Prof. Dr. med. Götz Thomalla (UKE) and Dr. med. Märit Jensen (UKE) have recorded a video on the new EAST-STROKE trial in layman’s terms.
The EAST-STROKE (‘Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE’) trial is led by scientist from the University Medical Centre Hamburg-Eppendorf (UKE) and investigates whether early rhythm-control treatment can effectively and safely prevent strokes. The project is funded by the EU as part of ‘Horizon Europe’. AFNET is partner for dissemination and exploitation.
ESC Congress 2024
AFNET associated events:
30th of August 2024, 10:27 am (CEST/German time) / 9:27 am (BST/British time): “Prague”, Adjunct pharmacology in PCI: beyond antiplatelet therapy, the next chapter – discussion (Renate Schnabel)
More Information
Do patients with device-detected atrial fibrillation and prior stroke benefit from anticoagulation?
A subgroup analysis of the NOAH – AFNET 6 trial revealed: In patients with device-detected atrial fibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. Paulus Kirchhof, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, in a late-breaking clinical trials session at the annual congress of the American Heart Rhythm Society (HRS) in Boston, USA, on 19.05.2024 (1).
Device-detected atrial fibrillation (DDAF) are short and typically rare episodes of atrial fibrillation (AF) detected by pacemakers, defibrillators, and implanted loop recorders capable of continuous rhythm monitoring. Device-detected atrial fibrillation is found in every fifth patient with a cardiac implanted electronic device (2). Device-detected atrial fibrillation can lead to stroke, but the stroke risk in patients with device-detected atrial fibrillation appears lower than the stroke risk in patients with ECG-documented atrial fibrillation (1%/year).
Anticoagulation effectively prevents stroke in patients with ECG-documented AF. It is particularly effective in patients with AF and a prior stroke or transient ischemic attack (TIA) who are at high risk of recurrent stroke. In patients with a prior stroke without ECG-documented AF, oral anticoagulants mainly increase bleeding with only a weak effect on ischemic stroke.
Heart Rhythm Congress 2024
16th of May 2024, 7:00 pm (CEST/German time) / 1:00 pm (EASTERN/Boston time): “160 – BCEC “, Cost Benefit Analysis: Where Does Remote Monitoring Land? (Thorsten Lewalter)
More information
17th of May 2024, 10:30 am (CEST/German time) / 4:30 pm (EASTERN/Boston time): “PO-01-190”, The Role Meta-analysis of RNAseq Data from Two Large Atrial Tissue Banks Identifies More than 8000 Transcripts Associated with AF and Suggests a Prominent Role for Mitochondrial Processes and Energy Metabolism: the CATCH ME and RACE V Consortia (various speakers)
More information
